• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Hospitals See Strong Financial Performance in April, Despite Rising Expenses

by Fred Pennic 06/03/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– U.S. hospitals and health systems continued to experience positive financial performance in April, with patient demand and revenues rising for the 12th consecutive month, according to new data from Strata Decision Technology.

– While hospitals and health systems experienced positive financial performance in April, rising expenses remain a concern. Continued monitoring of these trends will be crucial for understanding the overall health of the healthcare industry.

Key Findings:

  • 12th Consecutive Month of Revenue Growth: Gross hospital revenues saw double-digit increases across both inpatient and outpatient services, marking the 12th consecutive month of year-over-year (YOY) growth. Outpatient revenue led the way with a 15.3% increase, reflecting the ongoing demand for convenient outpatient care.
  • Steady Operating Margins: The median hospital operating margin remained stable at 4.7% for a second month, indicating healthy financial performance despite rising expenses.
  • Increased Patient Volumes: Patient volumes also rose across most measures, with outpatient visits experiencing the highest YOY increase (12.9%). Inpatient admissions were flat month-over-month but up 9.7% YOY, partly due to the expansion of the Two-Midnight Rule.
  • Rising Expenses: While revenues and volumes grew, hospitals faced continued pressure from expense increases. Total non-labor expense saw the biggest increase (10.5% YOY), driven by significant rises in supply (16.7%) and drugs (14.9%).

Hospital Performance Benchmarks:

  • Operating Margins: The median year-to-date operating margin remained at 4.7% for the second consecutive month. However, hospitals saw a 4.2 percentage point increase in the median change in operating margin from April 2023 to April 2024.
  • Expenses: Total non-labor expense had the biggest increase (10.5% YOY), driven by rising supply and drug costs. Total labor expense increased 4.1% YOY, while total expense was up 7.4% from April 2023.
  • Revenues: Gross hospital revenues experienced double-digit YOY growth in both inpatient and outpatient services. Outpatient revenue rose 15.3%, and inpatient revenue increased 11.7%, pushing overall gross operating revenue up 14.1% YOY.
  • Patient Volumes: Outpatient visits saw the highest YOY increase (12.9%), followed by emergency visits (3.3%) and observation visits (0.8%). Inpatient admissions were flat month-over-month but up 9.7% YOY.

Physician Practice Benchmarks:

  • Expenses: Physician practice expenses continued to rise, with the median total direct expense per physician FTE reaching $1.05 million for April annualized. This represents an 11.4% increase from 2023.
  • Revenues: Physician net revenue per FTE also increased, reaching $725,614 for April annualized, representing a 13.4% increase from 2023.
  • Productivity: Higher physician productivity, measured by physician work relative value units (wRVUs) per FTE, likely contributed to the revenue increase. The annualized metric rose to 6,350.95 for the month, up 9% from the previous year.

“Hospitals and health systems continue to see encouraging financial performance as we head into the second quarter of the year,” said Steve Wasson, chief data and intelligence officer at Strata Decision Technology. “The data indicate that many healthcare leaders are finding effective strategies to navigate persistent high expenses. They are successfully moving their organizations to more stable ground and away from narrower margins that plagued hospitals throughout 2023.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Patient Financial Services (PFS), Revenue Cycle Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |